A. Claessen

发表

Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.

G. Giaccone, C. Meijer, S. Meijer, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

M. Hanna, C. Meijer, E. Bloemena, 1999, The Lancet.

Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.

C. Meijer, P. Stern, E. Bloemena, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Linkage between Toll‐like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis

J. Grutters, M. Veltkamp, J. Grutters, 2007, Clinical and experimental immunology.

A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

G. Giaccone, C. Meijer, S. Meijer, 2002, British Journal of Cancer.

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis

J. Grutters, D. Hijdra, C. van Moorsel, 2016, Clinical and experimental immunology.

Rheumatoid factor isotype and Ro epitope distribution in primary Sjögren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca

J. Kelder, B. Meek, A. Claessen, 2018, Rheumatology International.

Tumor infiltrating leukocytes (tils) during progressive tumor growth and BCG-mediated tumor regression

R. Burger, P. Steerenberg, W. H. Jong, 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.

P. Zanen, J. Grutters, H. Ruven, 2015, Respiratory medicine.

Bronchoalveolar lavage cell pattern from healthy human lung

J. Grutters, D. Hijdra, H. Ruven, 2012, Clinical and experimental immunology.

The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B‐cell chronic lymphocytic leukaemia

R. van der Griend, G. Rijkers, D. Biesma, 2007, European journal of haematology.

Reversal of mucosal tolerance by subcutaneous administration of interleukin‐12 at the site of attempted sensitization

D. Wolvers, G. Kraal, B. von Blomberg, 1996, Immunology.

Oral tolerance is determined at the level of draining lymph nodes.

H. Savelkoul, G. Kraal, J. Brevé, 1995, Immunobiology.

PEG‐IL‐2 therapy of advanced cancer in the guinea pig. Impact of the primary tumor and beneficial effect of cyclopphosphamide

P. D. De Mulder, R. Scheper, P. Steerenberg, 1994, International journal of cancer.

Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.

G. Rijkers, M. D. de Groot, D. Biesma, 2007, Vaccine.

T cell activation profiles in different granulomatous interstitial lung diseases – a role for CD8+CD28null cells?

J. Grutters, J. V. D. van den Bosch, A. Claessen, 2009, Clinical and experimental immunology.

A Panel of Candidate Tumor Antigens in Colorectal Cancer Revealed by the Serological Selection of a Phage Displayed cDNA Expression Library1

J. Arends, H. Hoogenboom, S. Hufton, 2002, The Journal of Immunology.

Liposomes as drug carrier system for cis-diamminedichloroplatinum (II)

G. Storm, P. Steerenberg, W. H. Jong, 1988, Cancer Chemotherapy and Pharmacology.

Liposomes as a drug carrier system for cis-diamminedichloroplatinum (II). I. Binding capacity, stability and tumor cell growth inhibition in vitro

G. Storm, P. Steerenberg, W. H. Jong, 1987 .

Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation

R. Scheper, S. Meyer, H. Bril, 2004, Cancer Immunology, Immunotherapy.

Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis.

J. Grutters, M. Veltkamp, J. V. D. van den Bosch, 2008, Chest.

Locoregional administration of etoposide, but not of interleukin 2, facilitates active specific immunization in guinea pigs with advanced carcinoma.

C. Meijer, E. Bloemena, R. Scheper, 1992, Cancer research.

Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.

R. Scheper, J. Limpens, H. Valster, 1987, Methods and findings in experimental and clinical pharmacology.

Development of T cell-mediated immunity after autologous stem cell transplantation: prolonged impairment of antigen-stimulated production of γ-interferon

G. Rijkers, D. Biesma, H. Velzen-Blad, 2007, Bone Marrow Transplantation.

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

J. Grutters, V. Deneer, B. Meek, 2015, European Respiratory Journal.

Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography.

J. Grutters, H. Ruven, J. V. D. van den Bosch, 2009, Clinical immunology.

Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes

J. Grutters, D. Hijdra, G. Rijkers, 2012, Journal of Inflammation.

Variation in IL7R predisposes to sarcoid inflammation

J. Grutters, T. Huizinga, H. Ruven, 2009, Genes and Immunity.

Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.

P. Steerenberg, K. Wubs, C. Vendrik, 1989, Cancer research.

A multicentre verification study of the QuantiFERON®-TB Gold Plus assay.

H. Bax, V. Saegeman, J. D. de Steenwinkel, 2018, Tuberculosis.

Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?

J. Grutters, D. Hijdra, B. Meek, 2016, European Respiratory Journal.

Phenotypic Characterization of Human Intermediate Monocytes

J. Grutters, D. Hijdra, G. Rijkers, 2013, Front. Immunol..

Development of implantable antitumor devices based on polyphosphazenes, II

K. Groot, A. Claessen, J. H. Goedemoed, 1991 .

Development of injectable antitumor microspheres based on polyphosphazene

K. Groot, A. Claessen, R. Scheper, 1991 .

Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain.

K. Hoekman, H. M. Pinedo, M. Poot, 1997, British Journal of Cancer.

Reversal of Orally Induced T‐Cell Tolerance by Subcutaneous Administration of Interleukin‐12 at the Site of Attempted Sensitization

R. Scheper, D. Wolvers, G. Kraal, 1996, Annals of the New York Academy of Sciences.

Development of functional Haemophilus influenzae type b antibodies after vaccination.

D. Biesma, H. van Velzen-Blad, A. Claessen, 2005, Haematologica.

Tumor regression and induction of anti‐tumor immunity by local chemotherapy of guinea‐pigs bearing a line‐10 hepatocarcinoma

R. Scheper, P. Steerenberg, H. Bril, 1991, International journal of cancer.

Fresh colorectal tumor cells isolated from individual patients differ in their susceptibility to monocyte mediated cytotoxicity

R. Scheper, B. Schuurman, S. Meyer, 1995, Journal of surgical oncology.

The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B‐cell chronic lymphocytic leukaemia

R. van der Griend, G. Rijkers, D. Biesma, 2007, European Journal of Haematology.

Antinuclear antibodies do not predict anti-infliximab antibody induction in sarcoidosis.

J. Grutters, D. Hijdra, A. Vorselaars, 2013, Journal of the American Academy of Dermatology.